F

4D Molecular Therapeutics
D

FDMT

7.50000
USD
-0.11
(-1.38%)
مغلق
حجم التداول
28,738
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
346,707,818
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار

العنوان: 4D Molecular Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.